These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 1649329)
1. Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus. Alexandersen S; Carpenter S J Virol; 1991 Aug; 65(8):4255-62. PubMed ID: 1649329 [TBL] [Abstract][Full Text] [Related]
2. Structural and functional characterization of rev-like transcripts of equine infectious anemia virus. Rosin-Arbesfeld R; Rivlin M; Noiman S; Mashiah P; Yaniv A; Miki T; Tronick SR; Gazit A J Virol; 1993 Sep; 67(9):5640-6. PubMed ID: 8394464 [TBL] [Abstract][Full Text] [Related]
3. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. Leroux C; Issel CJ; Montelaro RC J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627 [TBL] [Abstract][Full Text] [Related]
4. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony. Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901 [TBL] [Abstract][Full Text] [Related]
6. Genetic variation of envelope gp90 gene of equine infectious anemia virus isolated from an experimentally infected horse. Pang H; Kong XG; Sentsui H; Kono Y; Sugiura T; Hasegawa A; Akashi H J Vet Med Sci; 1997 Dec; 59(12):1089-95. PubMed ID: 9450237 [TBL] [Abstract][Full Text] [Related]
7. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. Howe L; Leroux C; Issel CJ; Montelaro RC J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301 [TBL] [Abstract][Full Text] [Related]
8. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. Cook RF; Leroux C; Cook SJ; Berger SL; Lichtenstein DL; Ghabrial NN; Montelaro RC; Issel CJ J Virol; 1998 Feb; 72(2):1383-93. PubMed ID: 9445039 [TBL] [Abstract][Full Text] [Related]
9. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli. Payne SL; Rushlow K; Dhruva BR; Issel CJ; Montelaro RC Virology; 1989 Oct; 172(2):609-15. PubMed ID: 2552661 [TBL] [Abstract][Full Text] [Related]
10. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus. Payne SL; Pei XF; Jia B; Fagerness A; Fuller FJ J Virol; 2004 Mar; 78(5):2478-85. PubMed ID: 14963146 [TBL] [Abstract][Full Text] [Related]
11. EIAV genomic organization: further characterization by sequencing of purified glycoproteins and cDNA. Ball JM; Payne SL; Issel CJ; Montelaro RC Virology; 1988 Aug; 165(2):601-5. PubMed ID: 2841805 [TBL] [Abstract][Full Text] [Related]
12. The open reading frame ORF S3 of equine infectious anemia virus is expressed during the viral life cycle. Saman E; Breugelmans K; Heyndrickx L; Merregaert J J Virol; 1990 Dec; 64(12):6319-24. PubMed ID: 2173797 [TBL] [Abstract][Full Text] [Related]
13. Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus. Carpenter S; Alexandersen S; Long MJ; Perryman S; Chesebro B J Virol; 1991 Mar; 65(3):1605-10. PubMed ID: 1847479 [TBL] [Abstract][Full Text] [Related]
14. Multiple RNA splicing and the presence of cryptic RNA splice donor and acceptor sites may contribute to low expression levels and poor immunogenicity of potential DNA vaccines containing the env gene of equine infectious anemia virus (EIAV). Zhou W; Cook RF; Cook SJ; Hammond SA; Rushlow K; Ghabrial NN; Berger SL; Montelaro RC; Issel CJ Vet Microbiol; 2002 Aug; 88(2):127-51. PubMed ID: 12135633 [TBL] [Abstract][Full Text] [Related]